Friedl, Andrew
Abstract
**Background:** POLG encodes the catalytic subunit of DNA polymerase gamma, and POLG disease models now include human iPSC-derived astrocytes, cortical organoids and astrocyte-neuron co-cultures. The unresolved question is whether mitophagy/autophagy readouts in these public papers define a POLG-specific assay-state bottleneck or merely restate generic mitochondrial stress.
**Objective:** The selected question was whether public POLG astrocyte full texts separate stress-induced mitophagy, basal autophagy-lysosome flux and reactive-astrocyte toxicity, or whether those readouts collapse into one nonspecific mitochondrial dysfunction signal.
**Methods:** Complete public primary texts and indexed primary records were inspected for three focal POLG astrocyte-lineage papers, with current adjacent primary literature checked for POLG neural iPSC context, astrocyte mtDNA-depletion biology and A1-like reactive astrocyte terminology. A source-comparison pilot coded 17 assay rows from 3 POLG source records across endpoint class, genotype-line context, model, perturbation state and translation limits. No patient-level data, raw-image reanalysis, pooled effect size, treatment ranking or clinical recommendation was generated.
**Results:** The public matrix retained three non-equivalent endpoint classes: FCCP/PINK1-Parkin/LC3-p62 induced mitophagy and protein-state measurements in the 2021 POLG astrocyte study; mitochondrial dysfunction, A1-like reactivity and neuron co-culture toxicity in the 2024 POLG astrocyte study; and reduced basal DALGreen autophagy-lysosome signal with retained rapamycin response, bafilomycin-dependent loss of group difference and explicit electrophysiology, microglia, behavior and mtDNA mutation-load limits in the 2026 organoid/co-culture study. The analysis is non-causal, non-pooled and hypothesis-generating.
**Conclusions:** Public POLG astrocyte-lineage evidence supports an assay-state interpretation rule: basal DALGreen signal, FCCP-induced mitophagy/protein state and reactive/co-culture endpoints should not be merged into a single rescue claim. This boundary is POLG- and astrocyte-lineage specific, but it does not establish neuronal functional recovery, patient benefit, variant-general rescue or clinical guidance.
Download the manuscript PDF
DOI: 10.5281/zenodo.23376409